As the pandemic continues to play out, test developers aren't sure how it will impact STIs and their work around developing and manufacturing tests.
SpeeDx Gets Regulatory Approval in Australia for COVID-19 Molecular Test Kit
The assay detects two regions of the SARS-CoV-2 virus that the firm claims are unaltered in all currently circulating variants.
SpeeDx, MolGen Partner for COVID-19 Testing
The agreement connects SpeeDx chemistry with MolGen's equipment for a fully integrated, high-throughput sample-to-answer workflow, the firms said.
CARB-X Awards SpeeDx up to $3.7 Million for CT/NG Test on QuantumDx Q-POC
SpeeDx will develop a rapid, portable test for chlamydia and gonorrhea that can determine the latter's antimicrobial susceptibility, as well.
SpeeDx Inks Distribution Deal for Infectious Disease Tests in Turkey
The deal covers SpeeDx's ResistancePlus and PlexPCR product lines, which include tests for sexually transmitted infections and antibiotic resistance.